Track BWAY and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$308.97M
Enterprise Value$242.09M
Revenue (TTM)$52.32M
Net Income (TTM)$7.65M
Free Cash Flow (TTM)$16.29M
Financial Health
Cash$67.95M
Net Debt-$66.87M
Debt Ratio0.01
Debt to Equity0.01
Interest Coverage4.45
Valuation (TTM)
Price to Sales5.91
Price to Earnings40.38
EV to EBITDA24.19
Price to Book4.22
Price to Free Cash Flow18.97
Margins (TTM)
Gross Profit Margin75.42%
EBITDA Margin19.13%
Operating Income Margin8.29%
Net Income Margin14.63%
Free Cash Flow Margin31.14%
Returns (5Y Avg)
Return on Invested Capital-8.44%
Return on Assets-6.02%
Return on Equity-7.12%
Return on Total Capital-8.44%
Return on Capital Employed-6.55%
Dividend Summary
Dividend Yield-
Annual Dividend-
Payout Ratio-
Ex Dividend Date-
5-Year Dividend CAGR-
CAGR (5Y)
Revenue19.00%
Diluted EPS8.79%
Total Debt20.17%
Capital Expenditures-6.54%
Free Cash Flow34.91%
CAGR (3Y)
Revenue24.65%
Diluted EPS20.98%
Total Debt66.24%
Capital Expenditures-3.11%
Free Cash Flow1000.00%
CAGR (1Y)
Revenue28.34%
Diluted EPS386.09%
Total Debt30.46%
Capital Expenditures-53.59%
Free Cash Flow152.18%
$16.56+$0.41|+2.48%
Last updated: Jul 22, 4:00 PM ET
52W High$17.35
52W Low$5.68
50D SMA$15.10
200D SMA$12.08
Volume126.50K
Brainsway Ltd
16 Hartum St, Jerusalem, Israel, 9777516
IPO
1999
Employees
129
Industry
Medical Devices
Sector
Healthcare
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Insider Transactions
Quarterly buy vs. sell activity
No insider transactions data available for this period
Analyst Ratings
1 analysts covering
Buy100%recommend buy
Buy
1
Hold
0
Sell
0